BofA raised the firm’s price target on Texas Instruments (TXN) to $220 from $215 and keeps a Neutral rating on the shares. The Q4 call showed no evidence of demand recovery required to meet high Street expectations, the analyst tells investors. However, the firm raised its calendar year 2025 and 2026 EPS estimates by 6% and 1% to $5.38 and $6.43, respectively, mostly due to benefits of the CHIPS Act, along with a lower tax rate and Q1 outlook that was modestly above its forecast.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXN:
- Texas Instruments should be bought on any weakness, says Citi
- Texas Instruments Reports Mixed Q4 2024 Earnings
- Closing Bell Movers: Twilio up 14% on robust Investor Day outlook
- TXN Earnings: Texas Instruments Stock Falls on Weak Guidance
- Texas Instruments sees Q1 gross margin decreasing ‘a few hundred basis points’